Bicocca Open Archive

Logo unimib boa
GRASSI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 112.510
AS - Asia 57.622
EU - Europa 41.003
SA - Sud America 8.183
Continente sconosciuto - Info sul continente non disponibili 3.728
AF - Africa 1.304
OC - Oceania 155
Totale 224.505
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 105.845
SG - Singapore 20.766
CN - Cina 11.151
IT - Italia 9.804
VN - Vietnam 8.587
HK - Hong Kong 8.246
RU - Federazione Russa 6.728
BR - Brasile 6.096
SE - Svezia 6.094
CA - Canada 5.534
DE - Germania 4.367
IE - Irlanda 3.807
UA - Ucraina 2.748
GB - Regno Unito 1.930
BD - Bangladesh 1.886
FR - Francia 1.796
IN - India 1.434
FI - Finlandia 1.042
KR - Corea 898
AR - Argentina 735
TR - Turchia 683
ID - Indonesia 675
IQ - Iraq 557
AT - Austria 508
MX - Messico 479
NL - Olanda 407
PK - Pakistan 401
ZA - Sudafrica 400
EC - Ecuador 347
JP - Giappone 332
ES - Italia 327
PL - Polonia 307
SA - Arabia Saudita 293
CO - Colombia 286
PH - Filippine 283
VE - Venezuela 229
DK - Danimarca 198
UZ - Uzbekistan 188
MY - Malesia 169
CL - Cile 139
JM - Giamaica 138
MA - Marocco 134
PY - Paraguay 131
AU - Australia 128
EG - Egitto 124
KE - Kenya 124
TN - Tunisia 123
BE - Belgio 120
CR - Costa Rica 105
CZ - Repubblica Ceca 102
AE - Emirati Arabi Uniti 101
TW - Taiwan 90
PE - Perù 89
TH - Thailandia 89
JO - Giordania 86
ET - Etiopia 80
NP - Nepal 77
IR - Iran 74
PT - Portogallo 71
RO - Romania 68
LT - Lituania 67
KZ - Kazakistan 65
CH - Svizzera 64
GR - Grecia 63
HN - Honduras 60
UY - Uruguay 60
AZ - Azerbaigian 59
DZ - Algeria 57
LB - Libano 56
TT - Trinidad e Tobago 53
BO - Bolivia 52
EU - Europa 50
PS - Palestinian Territory 49
AL - Albania 47
BG - Bulgaria 47
DO - Repubblica Dominicana 46
NG - Nigeria 46
OM - Oman 42
IL - Israele 41
GT - Guatemala 40
NI - Nicaragua 40
SN - Senegal 40
SV - El Salvador 39
PA - Panama 37
HU - Ungheria 34
KG - Kirghizistan 34
RS - Serbia 31
BH - Bahrain 29
EE - Estonia 29
NO - Norvegia 29
BY - Bielorussia 28
PR - Porto Rico 27
SK - Slovacchia (Repubblica Slovacca) 23
SY - Repubblica araba siriana 22
BA - Bosnia-Erzegovina 21
LK - Sri Lanka 21
LV - Lettonia 21
NZ - Nuova Zelanda 21
CI - Costa d'Avorio 20
MU - Mauritius 20
Totale 220.386
Salva come PNG Salva come JPEG
Città #
Ann Arbor 12.308
Singapore 10.846
Ashburn 9.017
Hong Kong 8.117
Fairfield 6.270
Woodbridge 6.107
San Jose 5.782
Houston 4.694
Toronto 4.194
Dublin 3.630
Chandler 3.323
Milan 3.247
Wilmington 2.910
Jacksonville 2.878
Seattle 2.682
New York 2.607
Ho Chi Minh City 2.567
Frankfurt am Main 2.490
Dallas 2.068
Hanoi 2.060
Dearborn 2.035
Cambridge 2.018
Stockholm 1.964
Chicago 1.851
Santa Clara 1.787
Council Bluffs 1.716
Princeton 1.660
Hefei 1.654
Los Angeles 1.515
Beijing 1.489
The Dalles 1.419
Rome 972
Lauterbourg 904
Seoul 835
Lawrence 782
Moscow 727
Altamura 724
Nanjing 704
Boardman 667
Buffalo 598
São Paulo 519
Shanghai 513
San Diego 508
Lachine 461
Hangzhou 455
Helsinki 397
Phoenix 386
Vienna 378
Atlanta 361
Orem 357
Jakarta 353
Da Nang 335
Guangzhou 334
Columbus 295
Haiphong 282
Andover 277
Munich 277
London 269
Nanchang 246
Brooklyn 244
Baghdad 239
Figino 232
Denver 229
San Francisco 227
Tokyo 222
Salt Lake City 211
Shenyang 210
Warsaw 193
Changsha 191
Hebei 191
Montreal 190
Dong Ket 189
Rio de Janeiro 189
Ottawa 183
Tianjin 180
Nuremberg 178
Turin 169
Istanbul 161
Tashkent 160
Philadelphia 159
Chennai 158
Johannesburg 155
Jiaxing 143
Washington 142
Jinan 141
Falls Church 140
Brasília 135
Biên Hòa 131
Naples 131
Dhaka 128
Hải Dương 128
Norwalk 127
Miami 124
Tampa 123
Boston 122
Quito 120
Mumbai 119
Can Tho 116
Lahore 116
Lissone 116
Totale 137.583
Salva come PNG Salva come JPEG
Nome #
Behaviour of regional adrenergic outflow in mild-to-moderate renal failure 2.078
Diagnostic and Therapeutic Approach to Sleep Disorders, High Blood Pressure and Cardiovascular Diseases: A Consensus Document by the Italian Society of Hypertension (SIIA) 982
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 879
Assessment and management of exaggerated blood pressure response to standing and orthostatic hypertension: consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability 821
Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines 764
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension 756
The Sympathetic Nervous System in Hypertension: Roadmap Update of a Long Journey 651
Dual renin-angiotensin systemblockade and vascular remodeling: Is this a real advantage for vascular protection? 629
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 621
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 611
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 566
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 559
Sex-related relationships between uric acid and target organ damage in hypertension 510
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 508
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 500
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 498
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 493
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 485
Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 1: overview and the central role for catecholamines and sympathetic nervous system 466
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 466
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 462
Big data, observational research and P-value: a recipe for false-positive findings? A study of simulated and real prospective cohorts 457
Heart rate as a sympathetic marker during acute adrenergic challenge 451
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 434
Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials 424
Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension 413
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 403
Early alterations in left ventricular diastolic function in normotensive diabetic patients 402
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 401
Persistence of arterial functional abnormalities after successful coronary revascularization 400
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 400
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 399
Calcium antagonists and neural control of circulation in essential hypertension 397
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 392
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 391
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 390
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 387
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 384
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 381
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 380
A case of Pseudomonas Aeruginosa commercial tattoo infection 379
Differing associations for sport versus occupational physical activity and cardiovascular risk 378
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 375
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 374
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium 373
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 367
Statins and the risk of diabetes: Evidence from a large population-based cohort study 364
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 362
Reflex cardiovascular control in congestive heart failure 358
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 354
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 353
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 351
Flavanol-rich cocoa at breakfast: The right remedy after a sleepless night to prevent negative effects on blood pressure and cognition? 350
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 350
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 348
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 347
Heart rate as cardiovascular risk factor 347
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 345
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 344
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 343
Historical Archive of Blood Pressure and Evolution of Hypertension 342
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 341
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 341
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 340
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 339
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 339
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period. 339
The Pamela study: main findings and perspectives 337
Cardiopulmonary receptor regulation of renin release 336
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 336
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 335
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 334
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 334
Exploring the interplay between job strain and different domains of physical activity on the incidence of coronary heart disease in adult men 334
Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period 333
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 332
Pulse wave velocity progressione over a 3.7 years follow-up: focus on metabolic syndrome. 330
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 328
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 326
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 326
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 325
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 325
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 324
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 324
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 322
Neurogenic abnormalities in masked hypertension 318
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 318
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 318
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 317
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 317
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 317
Prognostic significance of masked tachycardia in hypertension: Evidence from a prospective international registry 317
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 316
Comparison between non-invasive and invasive pulse wave velocity assessment in human beings 316
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 315
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 315
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 313
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 313
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 313
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 309
Totale 42.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 736.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 736.117
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.900 0 0 0 930 814 744 526 679 638 762 978 1.829
2022/202314.314 2.112 4.076 1.131 1.153 862 2.360 194 817 889 109 400 211
2023/202411.472 322 293 482 532 1.772 2.742 2.129 325 1.204 226 212 1.233
2024/202531.683 1.760 3.941 1.278 1.366 2.575 926 1.539 1.204 3.523 4.124 3.456 5.991
2025/202680.996 8.086 5.966 5.890 7.638 7.574 3.917 9.810 3.526 5.925 8.153 7.167 7.344
2026/202720.573 3.778 5.732 9.501 1.562 0 0 0 0 0 0 0 0
Totale 224.505